On April 23, we suggested investors take a bullish posture on NVO, the maker of Ozempic (a popular diabetes therapy) and Wegovy (the popular weight loss drug). This article is for paid members - please login or subscribe for access. Username Password Remember Me Forgot Password Share: Mark W. Guthner, CFA Previous Post Apple Inc: AAPLNext PostDollar General: DG You Might Also Like Warner Brothers Discovery: WBD June 7, 2022 Morgan Stanley (MS) November 5, 2019 Hut 8, Inc. | HUT December 21, 2025
You Might Also Like Warner Brothers Discovery: WBD June 7, 2022 Morgan Stanley (MS) November 5, 2019 Hut 8, Inc. | HUT December 21, 2025
